501 related articles for article (PubMed ID: 18438853)
1. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept.
van der Heijde D; Landewé R; Einstein S; Ory P; Vosse D; Ni L; Lin SL; Tsuji W; Davis JC
Arthritis Rheum; 2008 May; 58(5):1324-31. PubMed ID: 18438853
[TBL] [Abstract][Full Text] [Related]
2. Etanercept in the longterm treatment of patients with ankylosing spondylitis.
Dijkmans B; Emery P; Hakala M; Leirisalo-Repo M; Mola EM; Paolozzi L; Salvarani C; Sanmarti R; Sibilia J; Sieper J; Van Den Bosch F; van der Heijde D; van der Linden S; Wajdula J
J Rheumatol; 2009 Jun; 36(6):1256-64. PubMed ID: 19411393
[TBL] [Abstract][Full Text] [Related]
3. Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks.
Davis JC; van der Heijde DM; Braun J; Dougados M; Cush J; Clegg D; Inman RD; Kivitz A; Zhou L; Solinger A; Tsuji W
Ann Rheum Dis; 2005 Nov; 64(11):1557-62. PubMed ID: 15843448
[TBL] [Abstract][Full Text] [Related]
4. Continuous efficacy of etanercept in severe and advanced ankylosing spondylitis: results from a 12-week open-label extension of the SPINE study.
Dougados M; Braun J; Szanto S; Combe B; Geher P; Leblanc V; Logeart I
Rheumatology (Oxford); 2012 Sep; 51(9):1687-96. PubMed ID: 22653382
[TBL] [Abstract][Full Text] [Related]
5. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.
Brandt J; Khariouzov A; Listing J; Haibel H; Sörensen H; Grassnickel L; Rudwaleit M; Sieper J; Braun J
Arthritis Rheum; 2003 Jun; 48(6):1667-75. PubMed ID: 12794835
[TBL] [Abstract][Full Text] [Related]
6. [Radiological progression and life quality analysis in ankylosing spondylitis patients using etanercept/methotrexate combination therapy].
Wang Y; Lian F; Li JP; Chen W; Yang XY; Yang NS; Yang JY; Meng QF
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(15):1022-5. PubMed ID: 21609635
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study.
Dougados M; Wood E; Combe B; Schaeverbeke T; Miceli-Richard C; Berenbaum F; Koppiker N; Dubanchet A; Logeart I
Arthritis Res Ther; 2014 Nov; 16(6):481. PubMed ID: 25428762
[TBL] [Abstract][Full Text] [Related]
8. Physical Function and Spinal Mobility Remain Stable Despite Radiographic Spinal Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors for Up to 10 Years.
Poddubnyy D; Fedorova A; Listing J; Haibel H; Baraliakos X; Braun J; Sieper J
J Rheumatol; 2016 Dec; 43(12):2142-2148. PubMed ID: 27803139
[TBL] [Abstract][Full Text] [Related]
9. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.
van der Heijde D; Landewé R; Baraliakos X; Houben H; van Tubergen A; Williamson P; Xu W; Baker D; Goldstein N; Braun J;
Arthritis Rheum; 2008 Oct; 58(10):3063-70. PubMed ID: 18821688
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis.
Calin A; Dijkmans BA; Emery P; Hakala M; Kalden J; Leirisalo-Repo M; Mola EM; Salvarani C; Sanmartí R; Sany J; Sibilia J; Sieper J; van der Linden S; Veys E; Appel AM; Fatenejad S
Ann Rheum Dis; 2004 Dec; 63(12):1594-600. PubMed ID: 15345498
[TBL] [Abstract][Full Text] [Related]
11. Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.
van der Heijde D; Salonen D; Weissman BN; Landewé R; Maksymowych WP; Kupper H; Ballal S; Gibson E; Wong R; ;
Arthritis Res Ther; 2009; 11(4):R127. PubMed ID: 19703304
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis.
Davis JC; van der Heijde DM; Braun J; Dougados M; Clegg DO; Kivitz AJ; Fleischmann RM; Inman RD; Ni L; Lin SL; Tsuji WH
Ann Rheum Dis; 2008 Mar; 67(3):346-52. PubMed ID: 17967833
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.
Davis JC; Van Der Heijde D; Braun J; Dougados M; Cush J; Clegg DO; Kivitz A; Fleischmann R; Inman R; Tsuji W;
Arthritis Rheum; 2003 Nov; 48(11):3230-6. PubMed ID: 14613288
[TBL] [Abstract][Full Text] [Related]
14. The paradoxical effects of TNF inhibitors on bone mineral density and radiographic progression in patients with ankylosing spondylitis.
Kang KY; Ju JH; Park SH; Kim HY
Rheumatology (Oxford); 2013 Apr; 52(4):718-26. PubMed ID: 23275389
[TBL] [Abstract][Full Text] [Related]
15. [A multicenter, double-blind, randomized, placebo-controlled clinical trial of etanercept treatment of Chinese patients with active ankylosing spondylitis].
Huang F; Zhang J; Zheng Y; Xu JH; Li XF; Wu HX; Chen ZW; Zhao Z; Zhang YM
Zhonghua Nei Ke Za Zhi; 2011 Dec; 50(12):1043-7. PubMed ID: 22333175
[TBL] [Abstract][Full Text] [Related]
16. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
Gorman JD; Sack KE; Davis JC
N Engl J Med; 2002 May; 346(18):1349-56. PubMed ID: 11986408
[TBL] [Abstract][Full Text] [Related]
17. Etanercept in adult patients with early onset ankylosing spondylitis.
Inman RD; Clegg DO; Davis JC; Whitmore JB; Solinger A
J Rheumatol; 2006 Aug; 33(8):1634-6. PubMed ID: 16881118
[TBL] [Abstract][Full Text] [Related]
18. Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly.
Braun J; McHugh N; Singh A; Wajdula JS; Sato R
Rheumatology (Oxford); 2007 Jun; 46(6):999-1004. PubMed ID: 17389658
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.
Brandt J; Listing J; Haibel H; Sörensen H; Schwebig A; Rudwaleit M; Sieper J; Braun J
Rheumatology (Oxford); 2005 Mar; 44(3):342-8. PubMed ID: 15561737
[TBL] [Abstract][Full Text] [Related]
20. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
Maksymowych WP; Poole AR; Hiebert L; Webb A; Ionescu M; Lobanok T; King L; Davis JC
J Rheumatol; 2005 Oct; 32(10):1911-7. PubMed ID: 16206346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
